Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents


Vitae Pharmaceuticals, Inc.

Unaudited Condensed Statements of Comprehensive Loss

 
  For The Six Months Ended
June 30,
 
 
  2014   2013  

Net loss

  $ (10,019,050 ) $ (8,723,330 )

Other comprehensive (loss) income:

             

Unrealized losses on marketable securities

    (612 )   (9,249 )
           

Comprehensive loss

  $ (10,019,662 ) $ (8,732,579 )
           
           

   

The accompanying notes are an integral part of these unaudited condensed financial statements.

F-35